Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

[18F]Fludarabine: a highly sensitive and specific radiotracer for lymphoma

Oct. 24, 2014

GMI-1051 improves efficacy of antibiotic treatments in models of Pseudomonas infection

Oct. 23, 2014

In vivo testing of novel GPR-directed [99mTc]demobesin mimics

Oct. 23, 2014

Early clinical data for maternal immunization with the trivalent GBS vaccine

Oct. 23, 2014

PNPLA3 gene polymorphism associated with gallbladder cholesterol polyps

Oct. 23, 2014

Clinical response maintained with long-term brodalumab therapy in patients with psoriasis

Oct. 23, 2014

Pharmacokinetic and safety data presented for Ryanodex

Oct. 22, 2014

Quadrivalent influenza vaccine well tolerated after intradermal administration

Oct. 22, 2014

Phase II data for QAX-576 in fistulizing Crohn's disease

Oct. 22, 2014

Promising phase I results presented for the anti-TNF antibody AVX-470

Oct. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...